Providing market intelligence for more than 35 years

In The News

On a Netflix free trial? A third of you will likely pay up

Almost one out of three people who use a free trial to try out a streaming video service end up subscribing, researcher Parks Associates said Monday.

That "sizeable portion" of trial users dwarfs the amount of people who abuse free try-outs, Parks senior analyst Glenn Hower said.

"There is a potential for free trial abuse, but only roughly 1 percent of consumers are 'serial trialers,'" he said. "Most consumers use trials for their intended purpose of trying out a service before deciding whether or not to continue as a paid subscriber."

Services, such as Hulu, Netflix and live-TV streamers like Sling TV, often offer a free period, one of the consumer-friendly patterns that have become standard for online video competitors -- and have made it easier for people get a sense of life as a cord-cutter. Traditional TV providers like cable and satellite have grappled with dwindling customer growth as more people opt for online alternatives.

From the article "On a Netflix free trial? A third of you will likely pay up" by Joan E. Solsman.

Previously In The News

Netflix Beware, Hulu Is the Dark Horse That Will Take Over 2016

On the other hand, achieving such a feat may not be as easy it seems. Data published by Parks Associates highlights that during the past 12 months, approximately 50% of Hulu’s subscribers have not opt...

Parks: Top 10 Connected Entertainment Disruptors

Parks Associates has hosted the final day of the company’s 20th annual CONNECTIONS conference in San Francisco with panel discussions moderated by the firm’s analysts and featuring executives from com...

Top 10 Streaming Services Ranked

Sling TV is on its way up and Sony PS Vue is still outside of the top 10 OTT services. Parks Associates released its 2016 top 10 service providers list showing a stable top 5 with indications that all...

TTA’s Week: Digital Health Funding, Execs’ Wish List, ActivePreventive Responds…And Theranos

We compare two major analyses of 2016 digital health funding, note a tender opportunity and an award in UK, and two more chapters of the Theranos Story. The ActiveProtective CEO responds to Reader and...